These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7224313)

  • 1. Recrudescence of Anaplasma marginale induced by immunosuppression with cyclophosphamide.
    Corrier DE; Wagner GG; Adams LG
    Am J Vet Res; 1981 Jan; 42(1):19-21. PubMed ID: 7224313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of dexamethasone on the recrudescence of Anaplasma marginale in splenectomized calves.
    Kuttler KL; Adams LG
    Am J Vet Res; 1977 Sep; 38(9):1327-30. PubMed ID: 921027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1984 Apr; 45(4):695-7. PubMed ID: 6731981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity related to challenge exposure of cattle inoculated with virulent and attenuated strains of Anaplasma marginale.
    Carson CA; Sells DM; Ristic M
    Am J Vet Res; 1977 Aug; 38(8):1167-72. PubMed ID: 911085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to anaplasma marginale.
    Rose JE; Amerault TE; Roby TO
    J Dairy Sci; 1971 Sep; 54(9):1330. PubMed ID: 5094703
    [No Abstract]   [Full Text] [Related]  

  • 6. Mapping of B-cell epitopes in the N-terminal repeated peptides of Anaplasma marginale major surface protein 1a and characterization of the humoral immune response of cattle immunized with recombinant and whole organism antigens.
    Garcia-Garcia JC; de la Fuente J; Kocan KM; Blouin EF; Halbur T; Onet VC; Saliki JT
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):137-51. PubMed ID: 15010223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologic and clinical responses of premunized, vaccinated, and previously infected cattle to challenge exposure by two different Anaplasma marginale isolates.
    Kuttler KL; Zaugg JL; Johnson LW
    Am J Vet Res; 1984 Nov; 45(11):2223-6. PubMed ID: 6084430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine anaplasmosis: susceptibility of seronegative cows from an infected herd to experimental infection with Anaplasma marginale.
    Lincoln SD; Zaugg JL; Maas J
    J Am Vet Med Assoc; 1987 Jan; 190(2):171-3. PubMed ID: 3818429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of naturally acquired chronic Anaplasma marginale infections with a long-acting oxytetracycline injectable.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1982 Dec; 43(12):2170-2. PubMed ID: 7165161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses of calves antigenically stimulated and challenge exposed with Anaplasma marginale during tick infestation or treatment with dexamethasone.
    Eckblad WP; Stiller D; Woodard LF; Kuttler KL
    Am J Vet Res; 1984 Mar; 45(3):431-6. PubMed ID: 6711969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immune response to virulent and attenuated Anaplasma marginale administered to cattle in live and inactivated forms.
    Carson CA; Sells DM; Ristic M
    Am J Vet Res; 1977 Feb; 38(2):173-9. PubMed ID: 842914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of vaccine-induced immunity to anaplasmosis without induction of persistent postvaccinal complement-fixing and agglutinating antibodies in yearling steers.
    Corrier DE; Johnson JS; Wagner GG
    Am J Vet Res; 1985 Mar; 46(3):583-6. PubMed ID: 3994127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of sequential coinfection with Anaplasma phagocytophilum and Anaplasma marginale in cattle.
    Hoar BR; Nieto NC; Rhodes DM; Foley JE
    Am J Vet Res; 2008 Sep; 69(9):1171-8. PubMed ID: 18764690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immune responses in calves with anaplasmosis.
    Buening GM
    Am J Vet Res; 1973 Jun; 34(6):757-63. PubMed ID: 4707561
    [No Abstract]   [Full Text] [Related]  

  • 15. Anaplasma marginale infections in American bison: experimental infection and serologic study.
    Zaugg JL; Kuttler KL
    Am J Vet Res; 1985 Feb; 46(2):438-41. PubMed ID: 3994109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of bovines using a DNA vaccine (pcDNA3.1/MSP1b) prepared from the Jaboticabal strain of Anaplasma marginale.
    de Andrade GM; Machado RZ; Vidotto MC; Vidotto O
    Ann N Y Acad Sci; 2004 Oct; 1026():257-66. PubMed ID: 15604503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune evasion and immunosuppression by Anaplasma phagocytophilum, the causative agent of tick-borne fever of ruminants and human granulocytic anaplasmosis.
    Woldehiwet Z
    Vet J; 2008 Jan; 175(1):37-44. PubMed ID: 17275372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplasma ovis in Idaho sheep.
    Magonigle RA; Eckblad WP; Lincoln SD; Frank FW
    Am J Vet Res; 1981 Feb; 42(2):199-201. PubMed ID: 7258767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of five daily intravenous treatments with oxytetracycline hydrochloride on the carrier status of bovine anaplasmosis.
    Magonigle RA; Renshaw HW; Vaughn HW; Stauber EH; Frank FW
    J Am Vet Med Assoc; 1975 Dec; 167(12):1080-3. PubMed ID: 1194114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of a second Anaplasma exposure on the success of treatment to eliminate Anaplasma carrier infections in cattle.
    Kuttler KL
    Am J Vet Res; 1983 May; 44(5):882-3. PubMed ID: 6869997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.